Drug Shortage Report for SANDOZ ENTACAPONE
Report ID | 132392 |
Drug Identification Number | 02380005 |
Brand name | SANDOZ ENTACAPONE |
Common or Proper name | SANDOZ ENTACAPONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ENTACAPONE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100FCT BO V1 CA |
ATC code | N04BX |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-01-22 |
Estimated end date | 2021-03-05 |
Actual end date | 2021-01-29 |
Shortage status | Resolved |
Updated date | 2021-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-02-01 | French | Compare |
v3 | 2021-02-01 | English | Compare |
v2 | 2021-01-25 | French | Compare |
v1 | 2021-01-25 | English | Compare |
Showing 1 to 4 of 4